arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Entera Bio Ltd.

ENTX

$3.01 ▼ -0.12 (-3.83%) at close

26 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Entera Bio Ltd. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $151.9M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -49.6% ↘

FCF / Share $-0.07 ↘

Trailing P/E 21.5x

Price / Book 20.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-7.31M

↓ -175.3% —

FCF / Share Free cash flow per share

$-0.07

↓ -6.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Revenue Growth YoY (%)	—	N/M	N/M	N/M	N/M	—	—	—	—	—	N/M	N/M	N/M	N/M	-91.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1244%)	-94.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1279%)	-59.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-845%)	-56.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-809%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	133.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-12.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	20.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-37.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	10.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-175.3% Weak ↓ Weak Declining Year-over-year change in net income	-36.5% Weak ↓ Weak Declining Year-over-year change in net income	-27.9% Weak ↓ Weak Declining Year-over-year change in net income	-5.9% Weak ↑ Weak Improving Year-over-year change in net income	-23.8% Weak → Weak Stable Year-over-year change in net income	-27.3% Weak ↓ Weak Declining Year-over-year change in net income	-18.2% Weak ↓ Weak Declining Year-over-year change in net income	-27.0% Weak ↓ Weak Declining Year-over-year change in net income	7.7% Fair ↓ Fair Declining Year-over-year change in net income	7.9% Fair ↓ Fair Declining Year-over-year change in net income	34.3% Excellent ↑ Excellent Improving Year-over-year change in net income	22.4% Good ↓ Good Declining Year-over-year change in net income	27.0% Excellent ↑ Excellent Improving Year-over-year change in net income	42.1% Excellent ↑ Excellent Improving Year-over-year change in net income	26.0% Excellent ↑ Excellent Improving Year-over-year change in net income	4.6% Caution ↑ Caution Improving Year-over-year change in net income	-23.6% Weak Weak Year-over-year change in net income	-64.8% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-98.8% Weak Weak Year-over-year change in free cash flow	—	—	—	35.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	9.9% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	-14.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-20.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-33.1% Weak Weak Compound annual revenue growth over 3 years	-19.4% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	20.5% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	-4.4% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	-11.2% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	-14.0% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	-18.3% Weak → Weak Stable Compound annual EPS growth over 3 years	—	-26.3% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-10.1% Weak Weak Compound annual EPS growth over 3 years	-15.7% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.31x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Return on Invested Capital (%)	-49.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-46.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-23.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-23.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-17.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-100.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-771%)	-32.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-23.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-21.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-15.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-13.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-29.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	-46.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-25.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-22.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-19.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-38.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-354%)	-28.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-288%)	-21.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-25.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-21.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-18.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-12.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-9.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-14.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Net Debt (USD)	$-11.31M	$-4.14M	$-7.11M	$-8.57M	$-10.86M	$-12.57M	$-8.66M	$-6.92M	$-9.06M	$-9.19M	$-11.02M	$-7.58M	$-9.13M	$-10.69M	$-12.31M	$-14.32M	$-17.28M	$-20.11M	$-24.89M	$-27.39M	$-26.93M	$-16.38M	$-8.59M	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.14	$0.07	$0.07	$0.07	$0.06	$0.06	$0.06	$0.08	$0.06	$0.05	$0.07	$0.08	$0.08	$0.08	$0.10	$0.11	$0.11	—	$0.15	$0.11	$0.10	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.07	$-0.06	—	$-0.05	—	$-0.03	—	—	—	$-0.05	—	—	—	$-0.06	—	—	—	—	—	$-0.07	$-0.09	—	—	—	—	—
Book Value per Share (USD)	$0.15	$0.23	$0.28	$0.33	$0.38	$0.43	$0.21	$0.18	$0.23	$0.25	$0.29	$0.22	$0.29	$0.35	$0.41	$0.50	$0.60	$0.69	$0.78	$0.92	$1.06	—	$0.36	—	—	—
Tangible Book Value per Share (USD)	$0.15	$0.23	$0.28	$0.33	$0.38	$0.43	$0.21	$0.18	$0.23	$0.25	$0.29	$0.22	$0.29	$0.35	$0.41	$0.50	$0.60	$0.69	$0.78	$0.92	$1.06	—	$0.36	—	—	—
Basic Weighted Avg Shares (shares)	50.45M	47.76M	—	47.09M	46.84M	43.38M	—	37.64M	37.09M	36.74M	—	28.81M	28.81M	28.81M	—	28.81M	28.81M	—	—	28.68M	24.72M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Working Capital (USD)	$16.79M	$10.92M	$13.10M	$15.44M	$17.47M	$19.59M	$7.80M	$6.23M	$8.30M	$8.63M	$10.17M	$5.99M	$7.95M	$9.88M	$11.51M	$14.00M	$16.73M	$19.31M	$22.17M	—	—	—	$7.27M	—	—	—
Total Equity (USD)	$7.27M	$10.69M	$13.10M	$15.23M	$17.26M	$19.38M	$8.08M	$6.45M	$8.53M	$8.86M	$10.39M	$6.24M	$8.23M	$10.08M	$11.75M	$14.31M	$17.27M	$19.75M	$22.57M	$26.28M	$26.28M	$15.65M	$7.51M	$13.77M	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$42.00K	$82.00K	$42.00K	$57.00K	—	$0.00	$0.00	$0.00	$0.00	$14.00K	$8.00K	$44.00K	$68.00K	$165.00K	$140.00K	$109.00K	$157.00K	—	—	—	—
Depreciation Expense (USD)	$9.00K	$7.00K	$7.00K	$8.00K	—	$8.00K	$11.00K	—	—	$13.00K	$13.00K	—	—	$14.00K	$16.00K	—	—	$16.00K	$14.00K	$15.00K	$15.00K	$9.00K	—	—	—	—
Net Income, GAAP (USD)	$-7.31M	$-3.50M	$-3.02M	$-3.20M	$-2.66M	$-2.57M	$-2.36M	$-3.02M	$-2.15M	$-2.02M	$-2.00M	$-2.38M	$-2.33M	$-2.19M	$-3.04M	$-3.07M	$-3.19M	$-3.78M	$-4.10M	$-3.21M	$-2.58M	$-2.30M	—	—	—	—
Operating Cash Flow (USD)	$-3.46M	$-3.09M	$-1.83M	$-2.50M	—	$-1.40M	$-1.47M	—	—	$-1.86M	$-2.62M	—	—	$-1.61M	$-2.01M	—	—	$-4.79M	$-2.51M	$-2.11M	$-2.12M	$-2.32M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 26 quarters

Entera Bio Ltd.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ENTX with peers